News

CRISPRMED24 Testimonial - Colette Rogers, Ph.D

CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of this year's CRISPRMED attendees have to say about the conference in this new video series by WeDoCRISPR!

By: WeDoCRISPR - Nov. 25, 2024
News

Colette Rogers PhD is a postdoctoral researcher at the University of Minnesota, working on the development of new gene-editing approaches to treat Fanconi anaemia. In this WeDoCRISPR video, she shares her thoughts on the inaugural CRISPR Medicine Conference which was held in Copenhagen in April 2024. Have a listen!

Tags

HashtagArticleHashtagNewsHashtagWeDoCRISPRHashtagCRISPRMED24HashtagCRISPRMED25

News: CRISPRMED24 Testimonial - Colette Rogers, Ph.D
CLINICAL TRIALS
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Chronic Hepatitis B, HBV, (NCT06680232)
Sponsors:
Precision BioSciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine